MVP Journal of Medical Sciences

Open Access Open Access  Restricted Access Subscription Access

Bacteriological Profile in Sputum and their Antibiogram among the Patients of Acute Exacerbation of COPD


Affiliations
1 Department of Respiratory Medicine, Dr. Vasantrao Pawar Medical College Hospital & Research Centre, Nashik - 422003, Maharashtra, India
 

Background and Objectives: Chronic Obstructive Pulmonary Disease (COPD) is an important cause of disability and death globally and scenario has been infact worsened. Acute exacerbation of COPD (AECOPD) is associated with airway inflammation resulting in increased air trapping, further obstruction of airways and deterioration of gas diffusion. Objectives: The objective of this study is to find out the bacteriological profile and their antibiogram in AECOPD and to study the clinical presentation of AECOPD patients. Materials and Methods: This is a cross sectional study comprising of 45 patients diagnosed with AECOPD. Before starting on antibiotics all patients sputum was sent for culture and sensitivity. All patients were instructed to collect early morning, deep coughed sputum into a sterile sputum container (preferably two). Results: The present study reveals that total 45 cases, 89% were males and 11% were females. The most common organisms isolated were gram negative bacilli (71%) and gram positive bacilli (29%). Pseudomonas aueroginosa was the commonest bacteria isolated (26.7%) followed by streptococcus pneumonia (22.2%), Klebsiella pneumoniae (20%). The drug sensitivity testing revealed that Ciprofloxacin with amikacin is the best empirical antibiotic followed by Cephalosporin with amikacin. Conclusion: AECOPD is more common in adult males above the age of fifty five years secondary to smoking practices. As an empirical therapy in AECOPD patients the best choice of antibiotic therapy would be Ciprofloxacin with amikacin. Other best monotherapy antibiotic would be piperacillin with tazobactam or cefoperazone with sulbactum

Keywords

AECOPD-Acute Exacerbation of Copd.
Font Size

User
Notifications

  • Gold intiative for chronic obstructive lung disease. Available from: www.goldcopd.org

  • Wedzicha AA, Hurst JR, Calverley PMA, Albert RK, Anzueto A. Management of COPD exacerbations: A European respiratory society/American thoracic society guideline. Eur Respir J. 2017; 49:1600791. https://doi.org/10.1183/13993003.00791-2016 PMid:28298398

  • Rodriguez- Roisin R. Toward consensus definition for COPD exacerbations. Chest. 2000; 117:398–401. https:// doi.org/10.1378/chest.117.5_suppl_2.398S

  • Macintyre N, Huang YC. Acute exacerbation and respiratory failure in COPD. Proc am thoracsoc. 2008; 5:530–5. https:// doi.org/10.1513/pats.200707-088ET PMid:18453367 PMCid: PMC2645331

  • Arora N., Daga MK, et al. Microbial pattern of acute infective exacerbation of chronic obstructive airway disease in a hospital based study. Indian Chest Dis Allied Sci. 2001; 43:157–62.

  • Seneff et al. Hospital and 1 year survival of patients admitted to ICU with AECOPD. JAMA. 1995; 274:1852–7. https:// doi.org/10.1001/jama.274.23.1852 https://doi.org/10.1001/ jama.1995.03530230038027 PMid:7500534

  • Sanjay S. Infectious etiology of acute exacerbations of chronic bronchitis. Chest. 2000; 117(May 5):375S–85S.

  • Nestor S, Torres A, et al. Bronchial microbial patterns in severe exacerbations of Chronic Obstructive Pulmonary Disease (COPD) requiring mechanical ventilation. AMJ Resp Crit Care Med. 1998; 157:1498–505. https://doi.org/10.1164/ajrccm.157.5.9711044 PMid:9603129

  • Sanjay S, Murphy TF. Bacterial infection in chronic obstructive pulmonary disease in 2000: A State-of-the-Art Review. Clinical Microbiology Reviews. 2001; 14(2):336–63. https:// doi.org/10.1128/CMR.14.2.336-363.2001 PMid:11292642 PMCid:PMC88978

  • Beasleyet V. Lung microbiology and exacerbations in COPD. Int J Chron Obstruct Pulmon Dis. 2012; 7:555– 69. DOI: 10.2147/COPD.S28286 https://doi.org/10.2147/ COPD.S28286

  • Michael SN. Antibiotic therapy of exacerbations of chronic bronchitis. Seminars in Resp Inf. 2000; 15(1):59–70. https:// doi.org/10.1053/srin.2000.0150059

  • Miravitlles M, Mayordomo C, Arte´s M, Sanchez-Agudo L, Nicolau F, Segu JL and on Behalf of the EOLO Group. Treatment of chronic obstructive pulmonary disease and its exacerbations in general practice. Respir Med 1999; 93: 173–9. https://doi.org/10.1016/S0954-6111(99)90004-5

  • Adams SG, Melo J, Luther M, Anzueto A. Antibiotics are associated with lower relapse rates in outpatients with acute exacerbations of COPD. Chest. 2000; 117:1345–52. https:// doi.org/10.1378/chest.117.5.1345 PMid:10807821

  • Vogel F. A guide to the treatment of lower respiratorytract infections. Drugs. 1995; 50(1):62–72. https://doi.org/10.2165/00003495-199550010-00006 PMid:7588090

  • Chawla K, et al. Bacteriological profile and their antibiogram from cases of acute exacerbations of chronicobstructive pulmonary disease: A hospital based study. JCDR.2008; 2(1):612–6.

  • Manino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC.Chronic obstructive pulmonary disease surveillance: United States, 1971-2000. MMWR Surveill Summ. 2002; 51:1–16.

  • Chen JC, Manino DM. Worldwide epidemiology of chronic obstructive pulmonary disease. Curr Opin Pulm Med. 1999; 5:93–9. https://doi.org/10.1097/00063198-19990300000003

  • Anthonisen NR, Manfreda J, Warren CP, et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 1987; 106:196–204. https://doi.org/10.7326/0003-4819-106-2-196 PMid:3492164

  • Bochen K, Krasowska A, Milaniuk S, Kulczyńska M, Prystupa A, Dzida G. Erythrocyte sedimentation rate- an old marker with new applications. JPCCR. 2011; 5(2):50–5.

  • Shaw JG, Vaughan A, Dent AG, O’Hare PE, Goh F, Bowman RV, et al. Biomarkers of progression of Chronic Obstructive Pulmonary Disease (COPD). J Thorac Dis. 2014 Nov; 6(11):1532–47. DOI: 10.3978/ j.issn.2072-1439.2014.11.33.

  • Eller J, Ede S, Schaberg T, Neiderman MS, Mauch H, Lode HO. Infective exacerbations of chronic bronchitis relation between bacteriological etiology and lung function.Chest. 1998; 113(6):1542–8. https://doi.org/10.1378/ chest.113.6.1542 PMid:9631791

  • Saxena S, Ramnani VK, Nema S, Tripathi K, Dave L, Srivastava N. Bacteriological profile in acute exacerbation of Chronic Obstructive Lung Disease (AECOPD). Ann Int Med Den Res. 2016; 2(5):MB01– MB06. https://doi.org/10.21276/aimdr.2016.2.5.MB1

  • Narayanagowda DS, Golia S, Jaiswal J, Manasa SS. A bacteriological study of acute exacerbation of chronic obstructive pulmonary disease over a period of one year. Int J Res Med Sci. 2015; 3:3141–6. https://doi.org/10.18203/2320-6012.ijrms20151152

  • El Korashy RIM, El-Sherif RH. Gram negative organisms as a cause of acute exacerbation of COPD. Egyptian Journal of Chest Diseases and Tuberculosis. 2014; 63:345–9. https:// doi.org/10.1016/j.ejcdt.2013.12.013


Abstract Views: 250

PDF Views: 83




  • Bacteriological Profile in Sputum and their Antibiogram among the Patients of Acute Exacerbation of COPD

Abstract Views: 250  |  PDF Views: 83

Authors

Gauri Kulkarni
Department of Respiratory Medicine, Dr. Vasantrao Pawar Medical College Hospital & Research Centre, Nashik - 422003, Maharashtra, India
Deependra Chaudhary
Department of Respiratory Medicine, Dr. Vasantrao Pawar Medical College Hospital & Research Centre, Nashik - 422003, Maharashtra, India
Anup Bhoyar
Department of Respiratory Medicine, Dr. Vasantrao Pawar Medical College Hospital & Research Centre, Nashik - 422003, Maharashtra, India
Sushma Dugad
Department of Respiratory Medicine, Dr. Vasantrao Pawar Medical College Hospital & Research Centre, Nashik - 422003, Maharashtra, India

Abstract


Background and Objectives: Chronic Obstructive Pulmonary Disease (COPD) is an important cause of disability and death globally and scenario has been infact worsened. Acute exacerbation of COPD (AECOPD) is associated with airway inflammation resulting in increased air trapping, further obstruction of airways and deterioration of gas diffusion. Objectives: The objective of this study is to find out the bacteriological profile and their antibiogram in AECOPD and to study the clinical presentation of AECOPD patients. Materials and Methods: This is a cross sectional study comprising of 45 patients diagnosed with AECOPD. Before starting on antibiotics all patients sputum was sent for culture and sensitivity. All patients were instructed to collect early morning, deep coughed sputum into a sterile sputum container (preferably two). Results: The present study reveals that total 45 cases, 89% were males and 11% were females. The most common organisms isolated were gram negative bacilli (71%) and gram positive bacilli (29%). Pseudomonas aueroginosa was the commonest bacteria isolated (26.7%) followed by streptococcus pneumonia (22.2%), Klebsiella pneumoniae (20%). The drug sensitivity testing revealed that Ciprofloxacin with amikacin is the best empirical antibiotic followed by Cephalosporin with amikacin. Conclusion: AECOPD is more common in adult males above the age of fifty five years secondary to smoking practices. As an empirical therapy in AECOPD patients the best choice of antibiotic therapy would be Ciprofloxacin with amikacin. Other best monotherapy antibiotic would be piperacillin with tazobactam or cefoperazone with sulbactum

Keywords


AECOPD-Acute Exacerbation of Copd.

References





DOI: https://doi.org/10.18311/mvpjms%2F2017%2Fv4%2Fi2%2F11048